Reuters logo
6 days ago
BRIEF-Dova Pharmaceuticals qtrly net loss per share, basic and diluted $0.32
August 10, 2017 / 8:10 PM / 6 days ago

BRIEF-Dova Pharmaceuticals qtrly net loss per share, basic and diluted $0.32

Aug 10 (Reuters) - Dova Pharmaceuticals Inc

* Dova Pharmaceuticals reports second quarter 2017 operating and financial results

* Qtrly net loss per share, basic and diluted $0.32 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below